Repurposing Therapies for Type 1 Diabetes for Kidney Protection
Repurposing Therapies for Type 1 Diabetes for Kidney Protection
Speaker: David Cherney, MD CM, PhD, FRCP(C)
Professor of Medicine, University of Toronto
Gabor Zellerman Chair of Nephrology Research, University of Toronto
Clinician Scientist - Division of Nephrology, University Health Network
Senior Scientist, Toronto General Hospital Research Institute
Director, Renal Physiology Laboratory, University Health Network
Educational Objectives:
- Repurposing therapies for T1D for kidney protection
- Review rationale for use of SGLT2 inhibition in type 1 diabetes
- Understand the role of mineralocorticoid receptor antagonism in type 1 diabetes
- Review the rationale for GLP1 receptor agonists in type 1 diabetes for kidney protection
To join the virtual Medical Grand Rounds on Microsoft Teams, please contact dom.communications [at] mcgill.ca () to have your name added to the JGH subscription list.
Hybrid Medical Grand Rounds are additionally in person at the Block amphitheatre, room B-106
The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Some Rounds were video recorded.